Dikkat eksikliği ve hiperaktivite bozukluğu (Turkish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Dikkat eksikliği ve hiperaktivite bozukluğu" in Turkish language version.

refsWebsite

Global rank Turkish rank

1^st place

4^th place

11^th place

2^nd place

4^th place

218^th place

269^th place

11^th place

589^th place

low place

5,134^th place

low place

cdc.gov

"Symptoms and Diagnosis". Attention-Deficit / Hyperactivity Disorder (ADHD). Division of Human Development, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention. 29 Eylül 2014. 7 Kasım 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Kasım 2014.

Coghill DR, Banaschewski T, Soutullo C, Cottingham MG, Zuddas A (Kasım 2017). "Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder". European Child & Adolescent Psychiatry. 26 (11). ss. 1283-1307. doi:10.1007/s00787-017-0986-y. PMC 5656703 $2. PMID 28429134.
Jain R, Katic A (Ağustos 2016). "Current and Investigational Medication Delivery Systems for Treating Attention-Deficit/Hyperactivity Disorder". The Primary Care Companion for CNS Disorders. 18 (4). doi:10.4088/PCC.16r01979. PMID 27828696.
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators (Ekim 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053). ss. 1545-1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577 $2. PMID 27733282.

Annie Murphy Paul (3 Mayıs 2013). "How Does Multitasking Change the Way Kids Learn?". 13 Nisan 2024 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Mayıs 2024.

Coghill DR, Banaschewski T, Soutullo C, Cottingham MG, Zuddas A (Kasım 2017). "Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder". European Child & Adolescent Psychiatry. 26 (11). ss. 1283-1307. doi:10.1007/s00787-017-0986-y. PMC 5656703 $2. PMID 28429134.
Jain R, Katic A (Ağustos 2016). "Current and Investigational Medication Delivery Systems for Treating Attention-Deficit/Hyperactivity Disorder". The Primary Care Companion for CNS Disorders. 18 (4). doi:10.4088/PCC.16r01979. PMID 27828696.
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators (Ekim 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053). ss. 1545-1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577 $2. PMID 27733282.

"Attention Deficit Hyperactivity Disorder". National Institute of Mental Health. Mart 2016. 23 Temmuz 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Mart 2016.

Nesrin Zaman (28 Aralık 2016). "Multitasking Nedir? Zararları Nelerdir?". 28 Mayıs 2024 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Mayıs 2024.

"Symptoms and Diagnosis". Attention-Deficit / Hyperactivity Disorder (ADHD). Division of Human Development, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention. 29 Eylül 2014. 7 Kasım 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Kasım 2014.
"Attention Deficit Hyperactivity Disorder". National Institute of Mental Health. Mart 2016. 23 Temmuz 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Mart 2016.
Nesrin Zaman (28 Aralık 2016). "Multitasking Nedir? Zararları Nelerdir?". 28 Mayıs 2024 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Mayıs 2024.
Annie Murphy Paul (3 Mayıs 2013). "How Does Multitasking Change the Way Kids Learn?". 13 Nisan 2024 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Mayıs 2024.